Gene-Pyrethroid Interaction in Alzheimer's disease

Information

  • Research Project
  • 10289120
  • ApplicationId
    10289120
  • Core Project Number
    R01ES027481
  • Full Project Number
    3R01ES027481-06S1
  • Serial Number
    027481
  • FOA Number
    PA-18-591
  • Sub Project Id
  • Project Start Date
    12/7/2018 - 5 years ago
  • Project End Date
    7/31/2022 - 2 years ago
  • Program Officer Name
    HOLLANDER, JONATHAN
  • Budget Start Date
    8/1/2021 - 3 years ago
  • Budget End Date
    7/31/2022 - 2 years ago
  • Fiscal Year
    2021
  • Support Year
    06
  • Suffix
    S1
  • Award Notice Date
    7/28/2021 - 3 years ago

Gene-Pyrethroid Interaction in Alzheimer's disease

Alzheimer?s disease (AD) is a progressive neurodegenerative brain disease and the most common cause of dementia worldwide. An estimated 5.8 million Americans age 65 and older are currently living with AD. There is currently no cure for this disease. Age is the most important risk factor for AD, but there are many other factors, including environmental exposures and genetic are thought to play a profound role. However, none of them alone is the sole factor in disease development and progression. To date, a substantial amount of effort has focused on to identify genetic contributors to AD. Among the growing list of susceptibility genes, only the apolipoprotein E (APOE) has been identified as an individual strong contributor to AD. Apolipoprotein E4 (APOE4) allele is considered to be the highest contributor of genetic risk to late onset AD. Environmental exposure to toxic chemicals, including pesticides, are increasingly being recognized for their ability to increase the risk of AD. Patients with AD seriously suffer from cognitive deficits. The hippocampus is one of the most affected brain areas in AD and is a major regulator of cognitive function. Learning and memory deficits are associated with disruption of adult hippocampal neurogenesis in experimental animals and humans. Recent studies demonstrate adult hippocampal neurogenesis is reduced in patients with AD. Pyrethroid insecticides are one of the most widely used agricultural and household insecticides. Recently, we reported that repeated adult exposure to a relatively low dose of deltamethrin (3mg/kg) causes profound cognitive deficits in mice, which was accompanied by ER stress and marked impairment of hippocampal neurogenesis. Further, the APOE4 genotype has been associated with enhanced ER stress response and dysfunction of adult hippocampal neurogenesis. Here we will determine whether repeated exposure to deltamethrin and APOE genotype interact to cause enhanced ER stress, reduced hippocampal neurogenesis and worsened cognitive function associated with AD.

IC Name
NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES
  • Activity
    R01
  • Administering IC
    ES
  • Application Type
    3
  • Direct Cost Amount
    214677
  • Indirect Cost Amount
    101973
  • Total Cost
    316650
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    113
  • Ed Inst. Type
    SCHOOLS OF PUBLIC HEALTH
  • Funding ICs
    NIA:316650\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    NAL
  • Study Section Name
    Neurotoxicology and Alcohol Study Section
  • Organization Name
    FLORIDA INTERNATIONAL UNIVERSITY
  • Organization Department
    PUBLIC HEALTH & PREV MEDICINE
  • Organization DUNS
    071298814
  • Organization City
    MIAMI
  • Organization State
    FL
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    331992516
  • Organization District
    UNITED STATES